Mandate

Vinge advises FSN in acquisition of the Baggium Group

January 15, 2010

Vinge has advised funds managed by FSN Capital in connection with the acquisition of the Baggium Group. FSN Capital has offices in Oslo, Stockholm and Copenhagen and manages FSN Capitals’ funds. An independent team consisting of 17 Scandinavian investors is focusing on Nordic growth companies within the mid-cap segment which demonstrate organic or acquisition led growth potential.

FSN was advised by partners Fabian Ekeblad and Mikael Ståhl together with associates Paula Röttorp, Nils Taro Lock and Sofia Graflund. Competition law advice was provided by partner Pär Remnelid and associate Johanna Lindman.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025